A carregar...
Complete resolution of erythrodermic psoriasis with first-line apremilast monotherapy
Erythrodermic psoriasis (EP) is the most serious type of psoriasis with high morbidity and mortality. First-line recommended therapies for EP, cyclosporine and infliximab have significant adverse effects. Cyclosporine increases the risk of hypertension, leucopenia, infections and renal failure. Infl...
Na minha lista:
| Publicado no: | BMJ Case Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6357920/ https://ncbi.nlm.nih.gov/pubmed/30709830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-226959 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|